Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs MobilEye Global Inc (MBLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs MobilEye Global Inc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $4.02B), while MobilEye Global Inc trades at $7.07 (market cap $6.08B). The key difference: MobilEye Global Inc is the larger of the two by market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, MobilEye Global Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and MobilEye Global Inc for 15 Days on average.
| EWTX | MBLY | |
|---|---|---|
Market Cap | $4.02B | $6.08B |
Volume | 1,446,128 | 9,825,806 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.35 | $15.33 |
52-Week Low | $14.89 | $6.56 |
Typical Hold Time | 0 Days | 15 Days |
Enterprise Value | $3.56B | $4.64B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Mobileye Global (MBLY) trades at $7.02, up 2.63% with bearish technical signals despite recent earnings beats. The company shows mixed fundamentals with strong revenue growth to $2.0B in 2026 but deep net losses widening to -$4.1B. Analyst sentiment remains cautiously optimistic with 57.7% buy ratings and a $10.77 price target, while institutional interest persists through recent investments and insider buying.
MBLY presents a high-risk opportunity with significant upside potential if autonomous driving adoption accelerates, but faces substantial execution risks amid persistent losses and competitive pressures. The stock's current valuation below book value offers margin of safety, though profitability challenges and negative cash flow trends in 2026 require careful monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About MobilEye Global Inc
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →
